The overlapping syndromes of the pick complex

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Frontotemporal dementia (FTD), previously known as Pick's disease, is a significant cause of dementia, particularly early-onset cases.
• FTD presents with diverse clinical symptoms, including behavioral changes, language impairment, and motor deficits, often overlapping with conditions like corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), and amyotrophic lateral sclerosis (ALS).

Purpose of the Study:

• To summarize recent advancements in the molecular biology of FTD.
• To present findings from a clinical cohort with a high rate of autopsy confirmation.
• To explore the molecular mechanisms underlying FTD and identify potential therapeutic targets.

Main Methods:

• Review of recent literature on FTD molecular biology.
• Clinical case study analysis of FTD patients with autopsy confirmation.
• Investigation of proteinopathies (TDP-43, FUS) and genetic mutations (Tau, progranulin) associated with FTD.

Main Results:

• FTD accounts for 12-15% of all dementias and 30-50% of early-onset dementias.
• While tauopathies are present in less than half of cases, the majority exhibit TDP-43 or FUS proteinopathies, which are also implicated in ALS.
• Mutations in Tau and progranulin genes on Chromosome 17 (Ch-17) provide insights into molecular pathways.

Conclusions:

• The molecular landscape of FTD is more complex than previously thought, with TDP-43 and FUS proteinopathies being predominant.
• Understanding these molecular underpinnings, including genetic factors, opens avenues for targeted pharmacological treatments for FTD.
• The convergence of clinical and molecular findings underscores the need for integrated diagnostic and therapeutic strategies.